198 related articles for article (PubMed ID: 19741036)
1. Comparison of blood-brain barrier transport of glial-derived neurotrophic factor (GDNF) and an IgG-GDNF fusion protein in the rhesus monkey.
Boado RJ; Pardridge WM
Drug Metab Dispos; 2009 Dec; 37(12):2299-304. PubMed ID: 19741036
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.
Pardridge WM; Boado RJ
Pharm Res; 2009 Oct; 26(10):2227-36. PubMed ID: 19609743
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody-glial-derived neurotrophic factor fusion protein penetrates the blood-brain barrier in the mouse.
Zhou QH; Boado RJ; Lu JZ; Hui EK; Pardridge WM
Drug Metab Dispos; 2010 Apr; 38(4):566-72. PubMed ID: 20075191
[TBL] [Abstract][Full Text] [Related]
4. GDNF fusion protein for targeted-drug delivery across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Wang Y; Pardridge WM
Biotechnol Bioeng; 2008 Jun; 100(2):387-96. PubMed ID: 18080333
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor.
Boado RJ; Lu JZ; Hui EK; Sumbria RK; Pardridge WM
Biotechnol Bioeng; 2013 May; 110(5):1456-65. PubMed ID: 23192358
[TBL] [Abstract][Full Text] [Related]
6. Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey.
Boado RJ; Hui EK; Lu JZ; Sumbria RK; Pardridge WM
Bioconjug Chem; 2013 Oct; 24(10):1741-9. PubMed ID: 24059813
[TBL] [Abstract][Full Text] [Related]
7. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor.
Coloma MJ; Lee HJ; Kurihara A; Landaw EM; Boado RJ; Morrison SL; Pardridge WM
Pharm Res; 2000 Mar; 17(3):266-74. PubMed ID: 10801214
[TBL] [Abstract][Full Text] [Related]
8. Selective plasma pharmacokinetics and brain uptake in the mouse of enzyme fusion proteins derived from species-specific receptor-targeted antibodies.
Zhou QH; Boado RJ; Pardridge WM
J Drug Target; 2012 Sep; 20(8):715-9. PubMed ID: 22845843
[TBL] [Abstract][Full Text] [Related]
9. Very High Plasma Concentrations of a Monoclonal Antibody against the Human Insulin Receptor Are Produced by Subcutaneous Injection in the Rhesus Monkey.
Boado RJ; Hui EK; Lu JZ; Pardridge WM
Mol Pharm; 2016 Sep; 13(9):3241-6. PubMed ID: 27513815
[TBL] [Abstract][Full Text] [Related]
10. Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier.
Pardridge WM; Boado RJ
Methods Enzymol; 2012; 503():269-92. PubMed ID: 22230573
[TBL] [Abstract][Full Text] [Related]
11. Insulin Receptor Antibody-α-N-Acetylglucosaminidase Fusion Protein Penetrates the Primate Blood-Brain Barrier and Reduces Glycosoaminoglycans in Sanfilippo Type B Fibroblasts.
Boado RJ; Lu JZ; Hui EK; Lin H; Pardridge WM
Mol Pharm; 2016 Apr; 13(4):1385-92. PubMed ID: 26910785
[TBL] [Abstract][Full Text] [Related]
12. Genetic engineering, expression, and activity of a fusion protein of a human neurotrophin and a molecular Trojan horse for delivery across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Pardridge WM
Biotechnol Bioeng; 2007 Aug; 97(6):1376-86. PubMed ID: 17286273
[TBL] [Abstract][Full Text] [Related]
13. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein.
Boado RJ; Hui EK; Lu JZ; Zhou QH; Pardridge WM
J Biotechnol; 2010 Mar; 146(1-2):84-91. PubMed ID: 20100527
[TBL] [Abstract][Full Text] [Related]
14. Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier.
Boado RJ; Zhang Y; Zhang Y; Pardridge WM
Biotechnol Bioeng; 2007 Feb; 96(2):381-91. PubMed ID: 16937408
[TBL] [Abstract][Full Text] [Related]
15. Brain and Organ Uptake in the Rhesus Monkey in Vivo of Recombinant Iduronidase Compared to an Insulin Receptor Antibody-Iduronidase Fusion Protein.
Boado RJ; Pardridge WM
Mol Pharm; 2017 Apr; 14(4):1271-1277. PubMed ID: 28279069
[TBL] [Abstract][Full Text] [Related]
16. IgG-single chain Fv fusion protein therapeutic for Alzheimer's disease: Expression in CHO cells and pharmacokinetics and brain delivery in the rhesus monkey.
Boado RJ; Lu JZ; Hui EK; Pardridge WM
Biotechnol Bioeng; 2010 Feb; 105(3):627-35. PubMed ID: 19816967
[TBL] [Abstract][Full Text] [Related]
17. Intravenous treatment of experimental Parkinson's disease in the mouse with an IgG-GDNF fusion protein that penetrates the blood-brain barrier.
Fu A; Zhou QH; Hui EK; Lu JZ; Boado RJ; Pardridge WM
Brain Res; 2010 Sep; 1352():208-13. PubMed ID: 20599807
[TBL] [Abstract][Full Text] [Related]
18. IgG-enzyme fusion protein: pharmacokinetics and anti-drug antibody response in rhesus monkeys.
Boado RJ; Hui EK; Lu JZ; Pardridge WM
Bioconjug Chem; 2013 Jan; 24(1):97-104. PubMed ID: 23249376
[TBL] [Abstract][Full Text] [Related]
19. Expression in CHO cells and pharmacokinetics and brain uptake in the Rhesus monkey of an IgG-iduronate-2-sulfatase fusion protein.
Lu JZ; Boado RJ; Hui EK; Zhou QH; Pardridge WM
Biotechnol Bioeng; 2011 Aug; 108(8):1954-64. PubMed ID: 21351076
[TBL] [Abstract][Full Text] [Related]
20. Genetic engineering of IgG-glucuronidase fusion proteins.
Boado RJ; Pardridge WM
J Drug Target; 2010 Apr; 18(3):205-11. PubMed ID: 19827970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
